1. Home
  2. KALV vs ESQ Comparison

KALV vs ESQ Comparison

Compare KALV & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.74

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$105.02

Market Cap

941.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
ESQ
Founded
N/A
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
941.0M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
KALV
ESQ
Price
$26.74
$105.02
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$32.60
$120.33
AVG Volume (30 Days)
4.5M
91.6K
Earning Date
07-09-2026
04-23-2026
Dividend Yield
N/A
0.76%
EPS Growth
N/A
14.20
EPS
N/A
1.40
Revenue
$50,000,000.00
N/A
Revenue This Year
$185.42
$35.15
Revenue Next Year
$59.23
$39.09
P/E Ratio
N/A
$75.00
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$87.54
52 Week High
$26.85
$119.86

Technical Indicators

Market Signals
Indicator
KALV
ESQ
Relative Strength Index (RSI) 74.83 45.08
Support Level $14.56 $104.58
Resistance Level N/A $111.41
Average True Range (ATR) 0.15 2.47
MACD 0.01 -0.28
Stochastic Oscillator 98.60 24.78

Price Performance

Historical Comparison
KALV
ESQ

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.

Share on Social Networks: